These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2972123)

  • 21. [Diseases associated with the HLA histocompatibility system].
    Mejías E
    Bol Asoc Med P R; 1981 Apr; 73(4):203-7. PubMed ID: 6975638
    [No Abstract]   [Full Text] [Related]  

  • 22. [The HLA-associated immunological mechanisms in rheumatic involvement of the myocardium].
    Afanas'ev IuI; Kadyrova RT; Iazdovskiĭ VV
    Ter Arkh; 1995; 67(8):56-9. PubMed ID: 7482339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunology of leprosy. New developments.
    Ottenhoff TH
    Trop Geogr Med; 1994; 46(2):72-80. PubMed ID: 8079394
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical significance of histocompatibility antigens of the HLA system in the development of ischemic heart disease].
    Timoshenko OL; Burka NI
    Vrach Delo; 1988 Nov; (11):38-40. PubMed ID: 3238975
    [No Abstract]   [Full Text] [Related]  

  • 25. [HLA antigens in patients with primary cardiomyopathy].
    Pietrzak M; Zebrowski A; Krzemińska-Pakuła M; Kaczmarek A; Miś J
    Kardiol Pol; 1988; 31(9):598-604. PubMed ID: 3244236
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HLA antigens in patients with mitral valve prolapse syndrome].
    Pietrzak M; Zebrowski A; Krzemińska-Pakuła M; Kaczmarek A; Miś J
    Kardiol Pol; 1988; 31(9):593-7. PubMed ID: 3244235
    [No Abstract]   [Full Text] [Related]  

  • 28. [HLA system and collagen diseases (author's transl)].
    Bueno M; Pérez-González J; Sarria A
    An Esp Pediatr; 1981 Jul; 15(1):13-22. PubMed ID: 6797335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA genes and disease susceptibility.
    Rodey GE
    Prog Clin Biol Res; 1984; 149():235-53. PubMed ID: 6429665
    [No Abstract]   [Full Text] [Related]  

  • 30. [Predisposition to the development of nephropathies, their clinical course and HLA phenotype].
    Ignatova MS; Turpitko OIu; Degtiareva EM; Tananov AT
    Ter Arkh; 1984; 56(7):24-8. PubMed ID: 6484828
    [No Abstract]   [Full Text] [Related]  

  • 31. [The factors of hereditary predisposition to lymphogranulomatosis].
    Zaretskaia IuM; Pivnik AV; Klinova EG; Rasstrigin NA; Khamaganova EG; Aleshchenko SM; Margolin OV
    Ter Arkh; 1998; 70(7):53-7. PubMed ID: 9742638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major histocompatibility complex.
    Goust JM
    Immunol Ser; 1993; 58():29-48. PubMed ID: 8424978
    [No Abstract]   [Full Text] [Related]  

  • 33. The HLA system and disease.
    Cudworth AG; Wolf E
    Clin Sci (Lond); 1981 Jul; 61(1):1-5. PubMed ID: 6788430
    [No Abstract]   [Full Text] [Related]  

  • 34. The HLA complex and its relationship to rheumatic diseases.
    Schiffenbauer J; Schwartz BD
    Rheum Dis Clin North Am; 1987 Dec; 13(3):463-85. PubMed ID: 3324201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
    Tatoń J; Czech A; Podgórski G
    Pol Tyg Lek; 1984 Aug; 39(34):1141-6. PubMed ID: 6390380
    [No Abstract]   [Full Text] [Related]  

  • 36. [Attempt at detecting DRW antigens in Moscow inhibitants].
    Zaretskaia IuM; Dolbin AG; Baranova FS; Durneva TS; Abramov VIu
    Probl Gematol Pereliv Krovi; 1979 Jan; 24(1):53-6. PubMed ID: 84381
    [No Abstract]   [Full Text] [Related]  

  • 37. [HLA and endocrine diseases susceptibility in Georgian population].
    Kurdgeliia MR; Lobzhanidze TV
    Georgian Med News; 2006 Feb; (131):90-3. PubMed ID: 16575143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
    Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
    J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic distribution of cervical cancer-associated human leucocyte antigens and cervical cancer incidence in Finland.
    Castro FA; Haimila K; Pasanen K; Kaasila M; Patama T; Partanen J; Surcel HM; Pukkala E; Lehtinen M
    Int J STD AIDS; 2007 Oct; 18(10):672-9. PubMed ID: 17945045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polymorphism of D6S2414 marker located in HLA (6p21.31) locus and genetic predisposition to Grave's disease in Moscow population].
    Chistiakov DA; Savost'ianov KV; Turakulov RA; Petunina NA; Trukhina LV; Kudinova AV; Balabolkin MI; Nosikov VV
    Mol Biol (Mosk); 2000; 34(1):24-7. PubMed ID: 10732335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.